Cardiovascular toxicologyLiraglutideMyocytesCardiacZincInsulin Resistance
Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.
Fatemeh Hosseinpourshirazi, Umur D Mendes, Zeynep B Aksoy, Dunya Aydos, Merve Sözer, Lubne Aljaser, Manolya Gundogdu, Suatnur Sık, Erkan Tuncay, Belma Turan, Yusuf Olgar
Published: 202610.1007/s12012-026-10095-x
Abstract
Aging and insulin resistance are intertwined factors in the development of metabolic diseases such as type 2 diabetes and cardiovascular disorders. Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promising cardioprotective…
Preview only. Read the full abstract at the source